262 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
POSTER SESSIONS
254
008
Association study of the excitatory amino acid
transporter EAAT2 and glycine transporter GlyT1
gene polymorphism with schizophrenia in the Polish
population
Wojciech Merk, Poland
Krzysztof Kucia, Malgorzata Kowalczyk, Jan Kowalski
009
The serotonin transporter polymorphism
(5-HTTLPR) and natural course of at risk mental
state for psychosis
Anton Vainila, Belarus
Maryna Skuhareuskaya
010
Associative memory impairments are associat-
ed with functional alterations within the memory
network in schizophrenia patients and their unaf-
fected first-degree relatives: an fMRI study
Viola Oertel-Knöchel, Germany
Michael Stäblein, Denisa Ghinea, Helena Storchak,
Dominik Kraft, Silke Matura, David Prvulovic, Andreas
Reif, Christian Knöchel
011
Activation of the motivation-related ventral
striatum during experience of delusion
Tuukka Raij, Finland
Tapani Riekki, Eva Rikandi, Teemu Mäntylä, Tuula
Kieseppä, Jaana Suvisaari
012
Brain-derived neurotrophic factor (BDNF) and
cognitive function of schizophrenic patients over a
6 months follow-up period
Rodrigo Nieto, Chile
Hernan Silva, Manuel Kukuljan, Cecilia Rojas, Alejandra
Armijo, Ruben Nachar, Alfonso Gonzalez, Carmen Paz
Castaneda, Cristian Montes, Ana Miranda, Leonor
Bustamante, Juana Villarroel
013
Increased BOLD signals elicited by high gamma
auditory stimulation of the left auditory cortex in
acute state schizophrenia
Hironori Kuga, Japan
Toshiaki Onitsuka, Yoji Hirano, Itta Nakamura, Naoya
Oribe, Shigenobu Kanba, Takefumi Ueno
014
Differential resting-state connectivity patterns
of the right anterior and posterior dorsolateral
prefrontal cortices (DLPFC) in schizophrenia
Natalia Chechko, Germany
015
Do aberrant neural oscillations contribute to
multisensory processing deficits in schizophrenia?
Daniel Senkowski, Germany
Johanna Balz, Yadira Roa Romero, Jürgen Gallinat,
Julian Keil
016
Dysfunctional connectivity patterns during
humor processing in patients with schizophrenia:
an event-related fMRI study
Philipp Berger, Germany
Florian Bitsch, Arne Nagels, Benjamin Straube, Irina
Falkenberg
017
It takes two: functional magnetic resonance
(fMRI) activation in both cerebral hemispheres is
associated with psychometric schizotypy
Alexander M. Rapp, Germany
Dorothee Mutschler, Franziska Purr, Michael Erb, Amelie
Schreier
018
Disloyal and well-disposed intentions modulate
brain responses differently in schizophrenia
Florian Bitsch, Germany
Philipp Berger, Arne Nagels, Irina Falkenberg, Benjamin
Straube
P-09
Poster Session
13:30– 15:00
|
Hall Budapest
TOPIC 3:
Psychotic disorders
Psychotic disorders: pharmacotherapy
Chair:
William Honer, Canada
001
Simplifying antipsychotic polypharmacy in
schizophrenia: is it possible, safe and useful?
Jose Maria Pelayo Teran, Spain
Yolanda Zapico Merayo, Andrea Fernandez Lozano,
Maria Mendez Franganillo, Nicolas Martin Navarro,
Maria Antonia Reguero Palacio, Mario Martinez Perez
002
What characteristics of patient are used by
psychiatrists in deciding the discontinuation of anti-
psychotic medication after first-episode psychosis?
Tagata Hiromi, Japan
Naohisa Tsujino, Taiju Yamaguchi, Naoyuki Katagiri,
Takahiro Nemoto, Masafumi Mizuno
003
Clinical and economic impact of switching to
long acting injectable 3rd generation antipsychotics
in a sample of psychotic patients: results from a
mirror study
Luis Jimenez Treviño, Spain
Esther Torio Ojea, Javier Caballer Garcia, Aida Garcia-
Rua, Juan Carlos Ortigosa, Marino Montes, Inmaculada
Serrano, Emilio Sotomayor, Angeles Paredes Sanchez,
Maria Suarez Alvarez
004
Long-acting injectable antipsychotics prescrip-
tion tendency in patients with schizophrenia and
dual disorders
Carlos Parro Torres, Spain
Daniel Hernandez-Huerta
005
Impact of mental health intensive case man-
agement (MHICM) on antipsychotic utilization and
rates of polypharmacy
Venkata Kolli, USA
Sriram Ramaswamy, David Driscoll, Subhash Bhatia